A new spinout has launched from the University of Birmingham targeting treatments for the leading causes of preventable blindness. Healome Therapeutics is developing a platform that delivers a ‘pro-healing’ microenvironment for causes of preventable blindness. The company’s platform will be targeted at ocular surface diseases, which are notoriously challenging conditions to treat, and have progressively […]
